- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06743178
The Effects of Mass Media Photographs on Drug-Related Stigma
December 16, 2024 updated by: Johns Hopkins Bloomberg School of Public Health
A Randomized Experiment to Test the Effects of Mass Media Photographs Related to Drug Use
The aim of this study was to evaluate the effects of exposure to drug-related photos used by the media on emotions, stigma towards people who use drugs, and public health services for this population.
Study Overview
Status
Completed
Intervention / Treatment
- Behavioral: Photo of a person injecting drugs
- Behavioral: Photo of EMS responding to an overdose (White)
- Behavioral: Photo of EMS responding to an overdose (Black)
- Behavioral: Photo of a person receiving treatment (Jail)
- Behavioral: Photo of a person receiving treatment (Community)
- Behavioral: Photo of a person in recovery (White)
- Behavioral: Photo of a person in recovery (Black)
- Behavioral: Photo of a family member of an overdose decedent
Detailed Description
This randomized experiment evaluated the impact of drug-related photographs used by the media on stigma towards people who use drugs.
A nationally representative sample of US adults was randomized to view different photos used in the media (a person injecting drugs, a person being resuscitated after an overdose, a person receiving treatment, a person in recovery, or a person who had lost a family member to an overdose) and then asked questions about their feelings towards people who use drugs and their acceptance of public health services to address the overdose crisis.
Study Type
Interventional
Enrollment (Actual)
3570
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Maryland
-
Baltimore, Maryland, United States, 21205
- Johns Hopkins Bloomberg School of Public Health
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- participant in existing web-based survey panel (NORC's AmeriSpeak)
Exclusion Criteria:
- not able to complete experiment and survey in English
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: No exposure control group
This group was not exposed to any drug-related photo.
|
|
|
Experimental: Photo of person injecting drugs
Participants randomized to this arm were exposed to a photo of a person injecting drugs.
|
Exposed to a photo of a person injecting drugs
|
|
Experimental: Photo of Emergency Medical Services (EMS) responding to an overdose (White)
Participants randomized to this arm were exposed to a photo of EMS responding to a white person who had overdosed.
|
Exposed to a photo of EMS responding to an overdose (White)
|
|
Experimental: Photo of EMS responding to an overdose (Black)
Participants randomized to this arm were exposed to a photo of EMS responding to a Black person who had overdosed.
|
Exposed to a photo of EMS responding to an overdose (Black)
|
|
Experimental: Photo of a person receiving treatment (Jail)
Participants randomized to this arm were exposed to a photo of a person receiving methadone treatment in jail.
|
Exposed to a photo of a person receiving treatment (Jail)
|
|
Experimental: Photo of a person receiving treatment (Community)
Participants randomized to this arm were exposed to a photo of a person receiving methadone treatment in a community setting.
|
Exposed to a photo of a person receiving treatment (Community)
|
|
Experimental: Photo of a person in recovery (White)
Participants randomized to this arm were exposed to a photo of a white person in recovery in their workplace.
|
Exposed to a photo of a person in recovery (White)
|
|
Experimental: Photo of a person in recovery (Black)
Participants randomized to this arm were exposed to a photo of a Black person in recovery in their workplace.
|
Exposed to a photo of a person in recovery (Black)
|
|
Experimental: Photo of a family member of an overdose decedent
Participants randomized to this arm were exposed to a photo of a person who had lost a family member to an overdose.
|
Exposed to a photo of a family member of an overdose decedent
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Positive and Negative Affect Scale (Angry)
Time Frame: Immediately post-exposure to photo intervention
|
Rating of feeling angry at the present moment.
Item from the Positive and Negative Affect Scale.
Measured on 5-point Likert scale with 1 indicating "not at all" and 5 indicating "extremely" their feeling angry at the present moment.
|
Immediately post-exposure to photo intervention
|
|
Positive and Negative Affect Scale (Sympathy)
Time Frame: Immediately post-exposure to photo intervention
|
Rating of feeling sympathy at the present moment.
Item from the Positive and Negative Affect Scale.
Measured on 5-point Likert scale with 1 indicating "not at all" and 5 indicating "extremely" their feeling sympathy at the present moment.
|
Immediately post-exposure to photo intervention
|
|
Positive and Negative Affect Scale (Disgust)
Time Frame: Immediately post-exposure to photo intervention
|
Rating of feeling disgust at the present moment.
Item from the Positive and Negative Affect Scale.
Measured on 5-point Likert scale with 1 indicating "not at all" and 5 indicating "extremely" their feeling disgust at the present moment.
|
Immediately post-exposure to photo intervention
|
|
Positive and Negative Affect Scale (Pity)
Time Frame: Immediately post-exposure to photo intervention
|
Rating of feeling pity at the present moment.
Item from the Positive and Negative Affect Scale.
Measured on 5-point Likert scale with 1 indicating "not at all" and 5 indicating "extremely" their feeling pity at the present moment.
|
Immediately post-exposure to photo intervention
|
|
Social Distance Scale (Family)
Time Frame: Immediately post-exposure to photo intervention
|
Rating of willingness to have person with substance use disorder marry into their family.
Item from the Social Distance Scale that measures one element of stigma (desire for social distance).
Measured on 5-point Likert scale with 1 indicating greater willingness and 5 indicating greater unwillingness to have a person with a substance use disorder marry into the family.
|
Immediately post-exposure to photo intervention
|
|
Social Distance Scale (Neighbor)
Time Frame: Immediately post-exposure to photo intervention
|
Rating of willingness to have person with substance use disorder as a neighbor.
Item from the Social Distance Scale that measures one element of stigma (desire for social distance).
Measured on 5-point Likert scale with 1 indicating greater willingness and 5 indicating greater unwillingness to have a person with a substance use disorder as a neighbor.
|
Immediately post-exposure to photo intervention
|
|
Social Distance Scale (Work Closely)
Time Frame: Immediately post-exposure to photo intervention
|
Rating of willingness to have person with substance use disorder work closely with them.
Item from the Social Distance Scale that measures one element of stigma (desire for social distance).
Measured on 5-point Likert scale with 1 indicating greater willingness and 5 indicating greater unwillingness to have a person with a substance use disorder work closely with them.
|
Immediately post-exposure to photo intervention
|
|
Social Distance Scale (close friend)
Time Frame: Immediately post-exposure to photo intervention
|
Rating of willingness to have person with substance use disorder as a close personal friend.
Item from the Social Distance Scale that measures one element of stigma (desire for social distance).
Measured on 5-point Likert scale with 1 indicating greater willingness and 5 indicating greater unwillingness to have a person with a substance use disorder as a close personal friend.
|
Immediately post-exposure to photo intervention
|
|
Feeling-Thermometer measure of warmth towards people with substance use disorders
Time Frame: Immediately post-exposure to photo intervention
|
Rating of warmth felt toward people with substance use disorder with 0 indicating extremely cold and 100 indicating extremely warm.
|
Immediately post-exposure to photo intervention
|
|
Rating of agreement that recovery is possible
Time Frame: Immediately post-exposure to photo intervention
|
Rating of agreement with statement "Recovery from a drug addiction is possible" on a 5-point Likert scale with 1 indicating strongly agree and 5 indicating strongly disagree.
|
Immediately post-exposure to photo intervention
|
|
Rating of willingness to have a drug treatment program in their neighborhood
Time Frame: Immediately post-exposure to photo intervention
|
Rating of willingness to have a drug treatment program in their neighborhood with 1 indicating greater willingness and 5 indicating greater unwillingness.
Measured via survey questionnaire.
|
Immediately post-exposure to photo intervention
|
|
Rating of willingness to have a syringe exchange program in their neighborhood
Time Frame: Immediately post-exposure to photo intervention
|
Rating of willingness to have a syringe exchange program in their neighborhood with 1 indicating greater willingness and 5 indicating greater unwillingness.
|
Immediately post-exposure to photo intervention
|
|
Rating of willingness to have a safe consumption site in their neighborhood
Time Frame: Immediately post-exposure to photo intervention
|
Participant's rating of willingness to have a safe consumption site in their neighborhood with 1 indicating greater willingness and 5 indicating greater unwillingness.
|
Immediately post-exposure to photo intervention
|
|
Number of participants having a family member with a substance use disorder
Time Frame: Immediately post-exposure to photo intervention
|
Personal experience of having a family member with a substance use disorder.
Three close-ended response options (Yes, No, Don't know) when asked if the participant has ever had a family member with a substance use disorder.
|
Immediately post-exposure to photo intervention
|
|
Number of participants having a close friend with a substance use disorder
Time Frame: Immediately post-exposure to photo intervention
|
Personal experience of having a close friend with a substance use disorder.
Three close-ended response options (Yes, No, Don't know) when asked if the participant has ever had a close friend with a substance use disorder.
|
Immediately post-exposure to photo intervention
|
|
Number of participants having substance use disorder
Time Frame: Immediately post-exposure to photo intervention
|
Personal experience of having a substance use disorder.
Three close-ended response options (Yes; No; Don't Know) when asked if the participant has ever had a substance use disorder.
Measured via survey questionnaire.
|
Immediately post-exposure to photo intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Alene Kennedy-Hendricks, PhD, Johns Hopkins Bloomberg School of Public Health
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 20, 2024
Primary Completion (Actual)
April 8, 2024
Study Completion (Actual)
April 8, 2024
Study Registration Dates
First Submitted
December 16, 2024
First Submitted That Met QC Criteria
December 16, 2024
First Posted (Actual)
March 25, 2025
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
December 16, 2024
Last Verified
December 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB00026173
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Opioid Use Disorder
-
Wake Forest University Health SciencesUniversity of Chicago; Rogers Behavioral Health; University of California Santa...RecruitingSubstance Use | Methamphetamine-dependence | Opioid Use | Opioid-use Disorder | Cocaine Use Disorder | Cocaine Use | Methamphetamine AbuseUnited States
-
Icahn School of Medicine at Mount SinaiNational Institute on Drug Abuse (NIDA)CompletedSubstance Use Disorder | Opioid Use Disorder | Heroin Use DisorderUnited States
-
Emory UniversityNational Institute on Drug Abuse (NIDA); Georgia Institute of Technology; CUNYCompletedSubstance-Related Disorders | Substance Abuse, Intravenous | Substance Use Disorders | Opioid Use | Substance Abuse | Opioid-use Disorder | Opioid Use Disorder, Severe | Substance WithdrawalUnited States
-
Vanderbilt University Medical CenterCompletedOpioid Use | Opioid-use DisorderUnited States
-
Center for Progressive Recovery, LLCNational Institute on Drug Abuse (NIDA); Yale UniversityCompletedCriminal Behavior | Opioid Use Disorder, Moderate | Opioid Use Disorder, SevereUnited States
-
Albert Einstein College of MedicineNational Institute on Drug Abuse (NIDA); Pfizer; National Institutes of Health...CompletedTobacco Use Disorder | Opioid-use DisorderUnited States
-
Indivior Inc.CompletedOpioid Use Disorder, Moderate | Opioid Use Disorder, SevereUnited States
-
Brigham and Women's HospitalOhio State UniversityActive, not recruitingOpioid Dependence | Opioid Use | Opioid-use DisorderUnited States
-
New York State Psychiatric InstituteNational Institute on Drug Abuse (NIDA); Columbia University; Weill Medical College... and other collaboratorsEnrolling by invitationOpioid Use | Opioid Court Model | Medication to Treat Opioid Use DisorderUnited States
-
Indiana UniversityCompletedOpioid Use | Opioid-use DisorderUnited States
Clinical Trials on Photo of a person injecting drugs
-
Rheumatology Therapeutics Medical CenterKochan Institute for Healing Arts ResearchUnknownPersons With Mild to Moderate Knee OsteoarthritisUnited States
-
Harvard UniversityCompletedResearcher-Subject RelationsUnited States
-
Jiangsu Province Centers for Disease Control and...Royal (Wuxi) Biological Co., LTDCompleted
-
University of California, Los AngelesNational Institute of Allergy and Infectious Diseases (NIAID); Los Angeles...CompletedRespiratory Tract Infections | InfluenzaUnited States
-
Skane University HospitalCompletedChronic Obstructive Pulmonary Disease (COPD)Sweden
-
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.Completed
-
University of California, San FranciscoBeth Israel Deaconess Medical Center; University of California, Davis; Agency...Enrolling by invitationHypertension | Blood Pressure Monitoring, HomeUnited States
-
CHRISTUS HealthTerminated
-
Beijing Chest HospitalUnknownNon-small Cell Lung CancerChina